JP Morgan Chase
NUVB icon

JP Morgan Chase’s Nuvation Bio NUVB Stock Holding History

JP Morgan Chase’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.18M Sell
539,162
-55,883
-9% -$311K ﹤0.01% 4035
2025
Q4 		$5.33M Sell
595,045
-80,555
-12% -$499K ﹤0.01% 3251
2025
Q3 		$2.5M Buy
675,600
+557,656
+473% +$1.52M ﹤0.01% 3916
2025
Q2 		$230K Buy
117,944
+30,830
+35% +$64.2K ﹤0.01% 5167
2025
Q1 		$153K Sell
87,114
-33,001
-27% -$75.1K ﹤0.01% 5365
2024
Q4 		$320K Sell
120,115
-322,798
-73% -$831K ﹤0.01% 5268
2024
Q3 		$1.01M Buy
442,913
+366,429
+479% +$1.12M ﹤0.01% 4458
2024
Q2 		$223K Buy
76,484
+18,314
+31% +$55.9K ﹤0.01% 5111
2024
Q1 		$212K Sell
58,170
-40,695
-41% -$78.1K ﹤0.01% 5321
2023
Q4 		$149K Sell
98,865
-638
-0.6% -$821 ﹤0.01% 5544
2023
Q3 		$133K Sell
99,503
-14,088
-12% -$23.4K ﹤0.01% 5317
2023
Q2 		$204K Buy
113,591
+23,661
+26% +$40.2K ﹤0.01% 5057
2023
Q1 		$149K Buy
89,930
+23,258
+35% +$47.1K ﹤0.01% 5237
2022
Q4 		$128K Buy
66,672
+1,793
+3% +$3.63K ﹤0.01% 5246
2022
Q3 		$145K Sell
64,879
-131,820
-67% -$376K ﹤0.01% 5108
2022
Q2 		$638K Sell
196,699
-518,701
-73% -$2.26M ﹤0.01% 4406
2022
Q1 		$3.76M Buy
715,400
+43,179
+6% +$243K ﹤0.01% 3241
2021
Q4 		$5.71M Buy
672,221
+620,362
+1,196% +$5.7M ﹤0.01% 2947
2021
Q3 		$516K Sell
51,859
-8,270
-14% -$75K ﹤0.01% 4701
2021
Q2 		$560K Buy
+60,129
New +$686K ﹤0.01% 4623

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase's NUVB Position: Q1 2026 in Review

JP Morgan Chase reduced its Nuvation Bio (NUVB) stake by 9.4% in Q1 2026, selling an estimated $311K and leaving 539,162 shares worth $2.18M. The position accounts for ﹤0.01% of the portfolio, ranked #4035.

JP Morgan Chase first reported a position in NUVB in Q2 2021 and has held it in 20 quarters since. The position peaked at $5.71M in Q4 2021. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • JP Morgan Chase held 539,162 shares of Nuvation Bio worth $2.18M as of Q1 2026.
  • JP Morgan Chase sold 55,883 Nuvation Bio shares in Q1 2026, an estimated $311K.
  • Nuvation Bio made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #4035 holding.
  • JP Morgan Chase first reported a position in Nuvation Bio in Q2 2021 and has held it in 20 quarters since.
  • JP Morgan Chase's Nuvation Bio position peaked at $5.71M in Q4 2021.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.